Terminal Illness Clinical Trial
Official title:
Is Acupuncture Able to Reduce Nausea and Vomiting in the Terminal Ill Patient
A comparative effectiveness research design was used. The sample size was calculated to 136 patients, who were randomized to an intervention group and a control group respectively. The patients were terminal ill patients enrolled to three in-bed hospices in Denmark and nausea and vomiting were measured using EORTC QlQ-c15-PAL (European Organisation for Research and Treatment of Cancer, Quality of Life Questionaire, core 15, Palliation)
The terminal ill patient is suffering from many different symptoms. In total 70% are
suffering from nausea and vomiting due to the wide spread of cancer or due to side effects of
treatment. Often the antiemetic's are not able to reduce symptoms to a level that enable the
patient to experience quality in life in the last days of his life. The investigators had
some experience with acupuncture as a complementary therapy but the investigators wanted more
systematically to investigate if acupuncture is able to reduce the terminal ill patient´s
nausea and vomiting. Literature show that acupuncture is able to reduce nausea and vomiting
in patients receiving chemotherapy, but there is no literature that support the ability of
acupuncture to reduce nausea and vomiting in the terminal ill patient.
The purpose of this study was to generate evidence based knowledge close to practice
regarding the effect of acupuncture in reducing nausea and vomiting in the terminal ill
patient.
Participants:
Terminal ill patients suffering from nausea and/or vomiting
Interventions:
The intervention group received usual care plus acupuncture for three days. The acupuncture
spots: Pericardium-6, Stomach-36, Liver-3 and Yin Tang were used. The control group received
usual care.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04078815 -
End-of-life Practices in 2019 vs. 2014
|
||
Recruiting |
NCT04750395 -
Comparing Haloperidol and Olanzapine in Treating Terminal Delirium
|
Phase 2 | |
Recruiting |
NCT06108375 -
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
|
N/A | |
Completed |
NCT04030910 -
'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life
|
N/A | |
Completed |
NCT04568629 -
ADJUST: A Study on MDT Prognostication
|
N/A | |
Completed |
NCT03520270 -
Prevalence of Potentially Inappropriate Treatments
|
||
Enrolling by invitation |
NCT05625854 -
Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness
|
N/A | |
Recruiting |
NCT04257227 -
Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness
|
N/A | |
Completed |
NCT04678310 -
iLIVE Volunteer Study
|
||
Completed |
NCT04456647 -
Parenteral Nutrition Therapy in Patients With Incurable Cancer
|
||
Completed |
NCT02362295 -
Prospective National Survey of the Palliative Situation Among Inmates in French Prisons
|
N/A | |
Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
Active, not recruiting |
NCT04950608 -
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
|
Phase 2 | |
Completed |
NCT03336489 -
Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
|
||
Completed |
NCT03392857 -
End Of Life in the Critically Ill patiEnt
|
||
Completed |
NCT03697213 -
The Surprise Study
|
||
Completed |
NCT01367613 -
Open-Label Treatment Extension of Protocol MNTX 302
|
Phase 3 | |
Recruiting |
NCT04612738 -
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
|
N/A | |
Completed |
NCT02067572 -
A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care
|
N/A | |
Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|